StephenXSkapekMD
Pediatric Hematology & Oncology • Durham, NCPediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Professor, Interim Chair, Department of Pediatrics, University of Texas Southwestern Medical Center
Dr. Skapek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-684-3401Fax+1 919-681-7950
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1994
San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1988 - 1991
Duke University School of MedicineClass of 1988
Certifications & Licensure
NC State Medical License 2024 - 2025
TX State Medical License 2011 - 2024
IL State Medical License 2007 - 2014
TN State Medical License 1999 - 2007
MA State Medical License 1991 - 1999- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2008 Aug 04
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Start of enrollment: 2010 Jul 01
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- A Novel Approach to Harnessing Acoustic A-Lines to Detect Circulating Tumor Cells in Flowing Blood.Shu Kang, Stephen Skapek, Sunil Krishnan, Sanjiv S Gambhir, Yushun Zeng
Nano Letters. 2024-12-11 - 5 citationsGermline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.Bailey A Martin-Giacalone, He Li, Michael E Scheurer, Dana L Casey, Shannon Dugan-Perez
JAMA Network Open. 2024-03-04 - 2 citationsGenomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.Funan He, Abhik M Bandyopadhyay, Laura J Klesse, Anna Rogojina, Sang H Chun
Nature Communications. 2023-11-22
Press Mentions
- Children’s Health Appoints New Chief of Cardiology for the Heart CenterSeptember 13th, 2021
UT Southwestern Develops System to Identify Genetic Anomalies Connected to CancerJuly 8th, 2018
Groundbreaking Genetic Research Could Help Diagnose and Cure Cancer in ChildrenJuly 6th, 2018- Join now to see all
Grant Support
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2012
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2012
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2010–2011
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2007–2011
- Translation Of Predictive Cancer Biomarkers Into Clinical PracticeNational Cancer Institute2009–2010
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2003–2007
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1999
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1998
- Cell Cycle Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
